Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 26 April, 2010 and appeared in  April10ISMPInterview

Why do you think errors in insulin administration are one of the most common mistakes made in pharmacies and hospitals, and what can we do to prevent those errors?

The way that insulin is administered often requires last-minute dose adjustments or changes in the type of insulin required. Unlike most other medications where a fixed dose is available....

Advertisement

this can make errors involving an improper dose or insulin type more likely. Also, unlike other drugs in hospitals, ordering and preparation of the dose may not involve the pharmacy, so an important independent check may not happen.

The frequency of administration also can lead to errors of omission (dose not given), and use of "U" for units of measurement can cause practitioners to misread the "U" for a number. In addition, there is confusing manufacturer labeling, a number of insulin products that have names that sound or look-alike, and a growing number of commercially available insulin mixes available and use of insulin pens in hospitals, which compound the likelihood of errors.

To reduce the likelihood of insulin errors, practitioners should design a preprinted order form or electronic order set for insulin that lists specific products, ingredients and component ratios, and have a pharmacy dispense doses wherever possible in order to take advantage of an independent system of checks. ISMP also recommends using only "units" and not "U" in insulin orders, and never using trailing zeros.

Problems associated with the use of insulin "pens," such as using a pen for more than a single patient, need to be addressed. Many other recommendations have appeared on ISMP's website or in our newsletters, and the Institute is planning a section on insulin safety for consumers on its consumer website (www.consumermedsafety.org).

If insulin is dispensed in vials, a pharmacy should label them for individual patients rather than supply them as a floor stock item but a process for retrieving discontinued vials must also be in place. Use of bar code scanning is recommended as well. Place reminders about potential confusion in computer systems and storage locations. Before making new or combination insulin products available, healthcare practitioners should conduct a failure mode and effects analysis to detect potential problems and take action before an error happens. Electronic medical records also afford the ability to print out current medications from the pharmacy computer to help prevent errors.

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 26 April, 2010 and appeared in  April10ISMPInterview

Past five issues: Issue 677 | Diabetes Clinical Mastery Series Issue 136 | Issue 676 | Diabetes Clinical Mastery Series Issue 135 | Issue 675 |

2013 Most Popular Articles:

AACE Releases New Comprehensive Diabetes Management Algorithm
Posted April 25, 2013
AACE - New Diabetes Guidelines Based on Tailored Approach
Posted May 09, 2013
Discovery Raises Hope for Type 1 Diabetes Reversal
Posted May 03, 2013
AACE: Ralph A. DeFronzo, MD -- Diabetes Prevention Supports More Aggressive and Earlier Intervention
Posted May 09, 2013
Intermittent Fasting May Improve Diabetes and Reduce Cardiovascular Risk
Posted May 03, 2013
AACE – New Test Efficiently Detects Diabetic Neuropathy
Posted May 09, 2013
AACE: CAD Risk for Pre-Diabetes Similar to Diabetes
Posted May 09, 2013
Low-Glycemic Diet Seen to Reverse Diastolic Dysfunction of Diabetes
Posted May 03, 2013
Diabetes Increases Cancer Risk by 20 Percent
Posted May 16, 2013
New Pill in the Works for Type 1 Patients
Posted April 19, 2013

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
Cast Your Vote
What test do you use to screen for prediabetes?

Navigate Diabetes In Control
CME/CE of the Week
Derek LeRoith, MD

Category: General Diabetes
Credits: .5


Advertisement


Search Articles On Diabetes In Control